These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1188 related items for PubMed ID: 17099030

  • 1. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D, Henig N, Morrissey B, Gotfried M.
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [Abstract] [Full Text] [Related]

  • 2. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
    Haworth CS, Bilton D, Chalmers JD, Davis AM, Froehlich J, Gonda I, Thompson B, Wanner A, O'Donnell AE.
    Lancet Respir Med; 2019 Mar; 7(3):213-226. PubMed ID: 30658914
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dual antibiotics for bronchiectasis.
    Felix LM, Grundy S, Milan SJ, Armstrong R, Harrison H, Lynes D, Spencer S.
    Cochrane Database Syst Rev; 2018 Jun 11; 6(6):CD012514. PubMed ID: 29889304
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC, Smyth AR.
    Cochrane Database Syst Rev; 2014 Nov 10; (11):CD004197. PubMed ID: 25383937
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection.
    VanDevanter DR, Gonda I, Dahms J, Cipolla D, Davis AM, Chalmers JD, Froehlich J.
    Clin Microbiol Infect; 2019 Dec 10; 25(12):1532-1538. PubMed ID: 31035017
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhaled tobramycin for chronic infection with pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis.
    Sangiovanni S, Morales EI, Fernández-Trujillo L.
    Respir Med; 2021 Jan 10; 176():106283. PubMed ID: 33307314
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis.
    Chorepsima S, Kechagias KS, Kalimeris G, Triarides NA, Falagas ME.
    Drug Des Devel Ther; 2018 Jan 10; 12():4059-4066. PubMed ID: 30568427
    [Abstract] [Full Text] [Related]

  • 15. Nebulized tobramycin in the treatment of adult CF pulmonary exacerbations.
    Al-Aloul M, Nazareth D, Walshaw M.
    J Aerosol Med Pulm Drug Deliv; 2014 Aug 10; 27(4):299-305. PubMed ID: 24219814
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review.
    Fjaellegaard K, Sin MD, Browatzki A, Ulrik CS.
    Chron Respir Dis; 2017 May 10; 14(2):174-186. PubMed ID: 27507832
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.